Evidence map›Paper›PMID 32327396›Full record

ArticleEuropean urology oncology2020

COVID-19 and Bacillus Calmette-Guérin: What is the Link?

Paul K Hegarty, John P Sfakianos, Gianluca Giannarini, Andrew R DiNardo, Ashish M Kamat

Registry-linked trialAbstract readEditorial
In one paragraph

Article in European urology oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05507671 (The Role of the Bacillus Calmette-Guérin Vaccine), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05507671 phase3active not recruitingnot on this mapstarted 2021, after this paper: background citation

The Role of the Bacillus Calmette-Guérin Vaccine (BCG) in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) Vaccines

TypeinterventionalSponsorOswaldo Cruz FoundationRan2021 to 2025Enrolled556ConditionsCOVID-19ArmsBCG (Bacillus Calmette-Guérin) vaccine, Placebo
3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Trial
  2. Article
  3. Frontiers in microbiology · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. The Impact of COVID-19 Disease on Urology Practice.Surgery journal (New York, N.Y.) · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul K HegartyDepartment of Urology, Mater Misericordiae University Hospital, Dublin, Ireland; Mater Private Hospital, Dublin, Ireland.
John P SfakianosDepartment of Urology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Gianluca GiannariniUrology Unit, Santa Maria della Misericordia Academic Medical Centre, Udine, Italy. Electronic address: gianluca.giannarini@hotmail.it.
Andrew R DiNardoThe Global Tuberculosis Program, Texas Children's Hospital, Immigrant Health and G. Baylor College of Medicine, Houston, TX, USA.
Ashish M KamatDepartment of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The debate around the role of vaccination with Bacillus Calmette-Guérin has revived right in the time of the Coronavirus disease 19 pandemic. Since Bacillus Calmette-Guérin is one of the most commonly delivered therapies in urology, in this editorial we discuss some points that we think will be of interest and guidance to practicing urologists during this public health emergency.

Indexed as

Health Services AccessibilityImmunizationAntineoplastic AgentsBCG VaccineBetacoronavirusCoronavirus InfectionsCOVID-19COVID-19 VaccinesEuropeHumansPandemicsPneumonia, ViralSARS-CoV-2Urologic NeoplasmsViral VaccinesAntineoplastic AgentsBCG VaccineCOVID-19 VaccinesViral Vaccines

Identifiers

PMID32327396
PMCPMC7152883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.